PubMed COVID-19 Clinical Care
57881 - 57890 of 60077 results found
Neutralizing Antibody Response of the Wild-Type/Omicron BA.1 Bivalent Vaccine as the Second Booster Dose against Omicron BA.2 and BA.5
Description
In addition to the original monovalent vaccines available for SARS-CoV-2, bivalent vaccines covering wild-type (WT) and Omicron BA.1 are also available. However, there is a lack of real-world data on the immunogenicity of bivalent vaccines as second
Longitudinal depression screening of frontline critical care nurses during the COVID-19 pandemic: A mixed-methods study
Description
CONCLUSIONS: More research is needed to evaluate critical care nurses who care for patients with COVID-19 and their levels of depression to improve practice at the bedside further and develop policies to promote their well-being.
Colchicine and risk of COVID-19-associated hospitalization
Description
In a recent population-based study conducted by Dr. Sáenz-Aldea and colleagues, colchicine was reported to have neutral influence to the risk of COVID-19 associated hospitalization and the susceptibility to COVID-19 viruses¹ . We studied the study
Toxoplasmosis in the practice of a neurologist
Description
Toxoplasmosis is a zoonotic protozoal disease characterized by a chronic course, polymorphism of clinical manifestations, predominant damage to the central nervous system, organs of vision, liver and lungs. The causative agent of the disease is the
Acute epiglottitis caused by COVID-19: A systematic review
Description
The COVID-19 pandemic has caused substantial population infections worldwide. COVID-19 has been reported to cause acute epiglottitis (AE); nonetheless, COVID-19-related AE is poorly understood by healthcare workers because of the disease's low
Correspondence on SARS-CoV-2 Vaccine Uptake Among Patients With Thoracic Malignancies
Description
No abstract
Management and outcomes of chest pain telemedicine visits in a cardiology clinic during the COVID-19 pandemic
Description
CONCLUSION: Our findings suggest that in-person evaluation for chest pain may aid in reducing the number of emergency department visits and hospital admissions when compared to telehealth evaluation.
Gut microbiome therapeutic modulation to alleviate drug-induced hepatic damage in COVID-19 patients
Description
Coronavirus disease 2019 (COVID-19) infection caused by the severe acute respiratory syndrome coronavirus 2 virus, its symptoms, treatment, and post-COVID-19 effects have been a major focus of research since 2020. In addition to respiratory symptoms
A false positive serology test of SARS‑CoV‑2 in a patient with Waldenström's macroglobulinemia: A case report
Description
The serology test of SARS-CoV-2 is one of the critical assays to make a diagnosis of SARS-CoV-2 infection. The gold immunochromatography assay (GICA) is a common measure to test SARS-CoV-2 specific IgG and IgM. The sensitivity and specificity of the
